Clinical Trial Update: An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating temozolomide plus radiation therapy with nivolumab or placebo for newly diagnosed glioblastoma has completed, with results posted in Fe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Brain Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2022-02-03